NEWS & EVENTS Event Calendars Event

Time & Date

2:00-3:45 PM, Monday, Jul 5th, 2021

Venue

Auditorium, 1st Floor, Building 5, Yunqi Campus

Host

Audience

Faculty and Staff,Graduate Students,Undergraduate Students

Category

Academics and Research

100th Westlake Master Forum | Weihong Tan:Aptamers Enable Molecular Medicine for “Healthy China and Healthy World”

Time: 2:00-3:45 PM, Monday, Jul 5th, 2021

Venue: Auditorium, 1st Floor, Building 5, Yunqi Campus



Speaker

Professor Weihong Tan holds a Ph.D. in physical chemistry from the University of Michigan (1992). He is currently the director of the Institute of Basic Medicine and Cancer, Chinese Academy of Sciences; the dean of the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); and the director of the Institute of Molecular Medicine at Shanghai Jiao Tong University and Renji Hospital. He is also a distinguished professor of chemistry and biology at Hunan University. Tan served as a University Distinguished Professor and a V.T. and Louis Jackson Professor at the University of Florida for more than 24 years before he became a full-time professor in China. He has been active in research and education in China since 2011.

Tan’s general research focus is in the fields of bioanalytical chemistry, chemical biology and molecular medicine. He specializes in molecular elucidation of diseases, aptamer research, DNA nanotechnology, and cancer theranostics. He has published over 700 peer-reviewed scientific papers. The total citations of his publications exceed 76,000, equating to an h-index of 149. According to Thomson Reuters, he has been among the “Highly Cited Researchers” from 2014-2020. He served as an associate editor for the Journal of the American Chemical Society (JACS) and Analytical Chemistry, and is currently an associate editor for CCS Chemistry. Tan has been in charge in establishing research institutes and laboratories, helping directing new research areas at Hunan University, Shanghai Jiaotong University and the Institute of Basic Medicine and Cancer at the Chinese Academy of Sciences. He has received over thirty five awards and honors, including the Beckman Young Investigator Award in 1997, the Pittcon Achievement Award in 2004, the AAAS Fellow in 2005, the American Chemical Society Florida Award in 2012, the Award in Spectrochemical Analysis from the American Chemical Society in 2018, the Prize for Scientific and Technological Progress, Ho Leung Ho Lee Foundation in 2018, the Ralph Adams Award for Bioanalytical Chemistry in 2019 and The Pittsburgh Analytical Chemistry Award in 2019. Tan is recognized as an Academician of the Chinese Academy of Sciences (2015), Academician of the World Academy of Sciences in Developing Countries (2016), and Member of the European Academy of Science (2019).


Title:

Aptamers Enable Molecular Medicine for “Healthy China and Healthy World”

Abstract:

The implementation of the "Healthy China" is a fundamental national policy of China. Alongside tremendous achievements in social and economic development, the people’s pursuit and yearning for health and happiness have never ceased. The outbreak of COVID-2019 further demonstrates the importance, challenge and significance of developing “Healthy China” for the great rejuvenation of the Chinese nation. Developing the health industry and promoting the building of “Healthy China” are the responsibility and mission of Chinese scientists and researchers. Modern medicine has entered the era of molecular medicine. Precision diagnosis and targeted therapy are therefore paramount in the development of modern medicine and the implementation of the "Healthy China " Molecular medicine is related to the illustration of mechanisms underlying the occurrence and progress of diseases, diagnosis and intervention of diseases, and prediction and prevention of diseases, at the molecular level. It requires molecular recognition, but effective molecular recognition tools in the clinic are lacking. Therefore, molecular scientists are of great significance and are responsible for promoting the advancement of molecular medicine. The impetus of our innovation is to solve the challenges and problems in biomedicine, but innovation must return to molecular science. Biomedicine must also embrace molecular science to make it useful. This talk will introduce our latest research progress in this field, especially in aptamer research and development, and discuss the broad prospects for application and huge potential of molecular science in the diagnosis, treatment, mechanism, and prevention of human diseases. The development of molecular medicine will definitely promote a healthier and happier human life.

 (The lecture will be given in Chinese)


Contact:

biguanying@westlake.edu.cn






Time & Date

2:00-3:45 PM, Monday, Jul 5th, 2021

Venue

Auditorium, 1st Floor, Building 5, Yunqi Campus

Host

Audience

Faculty and Staff,Graduate Students,Undergraduate Students

Category

Academics and Research